The rotating negotiator asks for a number in writing before he yields the seat

Who ages first? Torvald Reslund wants that answered in writing, notarized, with an official's name attached, before he hands his chair to whoever the lottery draws next.

He is in the second week of a five-week rotating seat he cannot renew. He has done the one thing eleven predecessors did not: he has stopped negotiating. Reslund told the Meridian Longevity Institute's renewal board this week that he will not reopen talks on the coastal waitlist until the Institute certifies its actual therapy throughput — the number of people it can move through treatment per transfer cycle — under signature. Not an estimate. A signature.

"I am not here to bargain over a list," Reslund said from the occupied atrium. "I am here to find out whether the list was ever real. Those are different negotiations. The second one comes first."

The demand lands where the Institute is thinnest. By its own filing with the Charter Court, the usable therapy pool runs to a few thousand seats. That is a fraction of the number that circulated for years among the Assembly's signatories, the number against which an estimated eleven thousand people were queued for capacity that did not exist. The Institute has since cut its own cited figure by roughly a third. No official ever certified the original number. No official has certified this one either.

A waitlist implies a line that moves. Throughput is the speed it moves at. The Institute has never published one it will stand behind. Ask it three ways and it comes apart the same way each time. How many seats actually clear per cycle? Who verified them? And why has a body that decides who gets more years never once been made to say?

"Certification is not a concession, it is arithmetic," Reslund said. "They can produce it this afternoon if it exists."

It does not exist, or at least the board has not produced it. Presiding Chair Halvard Sunde — who filed a sixty-day retirement notice with fifty-eight days still on the clock at the time of the court hearing — did not appear at the atrium this week. Convenient. The renewal board seats nine: seven drawn by lot, two appointed outright. Those two appointed chairs have now outlasted eleven straight rotating negotiators sent to ask them the same question. Reslund said this to the board's own liaison without softening it, and he was right not to.

That asymmetry is not an accident. It is the design. The occupation rotates its voice every five weeks by lottery. The incumbents rotate nothing at all. Ingrid Aaberg served thirty-eight days and handed off clean. Reslund inherited her mandate and roughly three weeks to spend it. The chairs inherit only more time, and they spend it very well.

Whether a rotating seat can outlast an incumbent's patience is the experiment running in that atrium right now. Reslund has narrowed the fight to one deliverable — a single number, signed — which makes it harder to stall and harder to fog over with the phrase the board prefers, "clinical prioritization."

"When I stand up, the next name from the lottery sits down," he said. "They will ask the same question I did. I would like the answer waiting for them."

So would I.